17 alpha-hydroxyprogesterone caproate has been researched along with aminoglutethimide in 2 studies
| Studies (17 alpha-hydroxyprogesterone caproate) | Trials (17 alpha-hydroxyprogesterone caproate) | Recent Studies (post-2010) (17 alpha-hydroxyprogesterone caproate) | Studies (aminoglutethimide) | Trials (aminoglutethimide) | Recent Studies (post-2010) (aminoglutethimide) |
|---|---|---|---|---|---|
| 517 | 88 | 251 | 1,489 | 135 | 56 |
| Protein | Taxonomy | 17 alpha-hydroxyprogesterone caproate (IC50) | aminoglutethimide (IC50) |
|---|---|---|---|
| Aromatase | Homo sapiens (human) | 5.043 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.27 | |
| Aromatase | Rattus norvegicus (Norway rat) | 6.2 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, XS; Zhang, X | 1 |
| Cao, B; Zhang, X | 1 |
2 trial(s) available for 17 alpha-hydroxyprogesterone caproate and aminoglutethimide
| Article | Year |
|---|---|
[Comparison between the roles of aminoglutethimide and hydroxyprogesterone caproates in the treatment of endometrial cancer].
Topics: 17 alpha-Hydroxyprogesterone Caproate; Aminoglutethimide; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Double-Blind Method; Endometrial Neoplasms; Estradiol; Female; Humans; Hydroxyprogesterones; Middle Aged; Progesterone | 1995 |
Exploration for drug therapy in endometrial carcinoma.
Topics: 17 alpha-Hydroxyprogesterone Caproate; Adenocarcinoma; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Carcinoma, Squamous Cell; Double-Blind Method; Endometrial Neoplasms; Female; Humans; Hydroxyprogesterones; Middle Aged; Tamoxifen | 1996 |